Latest News & Updates
Breaking News
3 hours ago
Simantini Singh Deo
Other trending news you may like to read
Beacon Therapeutics Begins LANDSCAPE Trial With First Patient Dosed In laru-zova Study For X-Linked Retinitis Pigmentosa
Beacon Therapeutics treats first patient in LANDSCAPE trial evaluating bilateral laru-zova gene therapy for X-linked retinitis pigmentosa.
Simantini Singh Deo
Cellectar Biosciences Signs Strategic Supply Agreement With Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapy Development
Cellectar Biosciences signs multi-year deal with Ionetix for Ac-225 and At-211 supply to support targeted alpha therapy programs.
Simantini Singh Deo
Recludix Pharma Receives FDA Clearance for Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Begin Clinical Trials
Recludix Pharma gets FDA clearance for Phase 1 trial of REX-8756, an oral STAT6 inhibitor for treating inflammatory diseases.
Simantini Singh Deo
PolyPid Appoints Experienced MedTech Executive Brooke Story As Chairman Of Its Board Of Directors
PolyPid appoints Brooke Story as Board Chair to guide growth and commercialization of its surgical infection prevention programs.
Simantini Singh Deo
